Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GelSight is a technology company specializing in high-resolution tactile sensing and 3D surface imaging, originally developed at the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL). The company's proprietary technology uses a compliant elastomeric sensor to capture the microscopic topography of any surface with sub-micron precision, regardless of the material's lighting or transparency. In the healthcare and life sciences sectors, GelSight's portable handheld devices are utilized for dermatology, wound assessment, and the high-precision inspection of medical device components. By providing immediate digital 3D visualization and quantification, the platform replaces traditional manual inspection and qualitative tactile assessments with objective data. The company serves a broad range of industries, including aerospace, forensics, and robotics, alongside its clinical and medical manufacturing applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GelSight.